|
End-of-day quote
Taipei Exchange
2026-09-04
|
5-day change | 1st Jan Change | ||
| 30.15 TWD | -1.31% |
|
-4.89% | -23.91% |
| 08-11 | Center Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-13 | Center Laboratories says Jan-Mar net profit at T$1.97 bln | RE |
Company Valuation: Center Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 31,736 | 30,555 | 28,132 | 30,630 | 31,591 | 31,056 |
| Change | - | -3.72% | -7.93% | 8.88% | 3.14% | -1.69% |
| Enterprise Value (EV) 1 | 34,577 | 31,068 | 29,252 | 32,827 | 36,070 | 35,097 |
| Change | - | -10.15% | -5.84% | 12.22% | 9.88% | -2.7% |
| P/E | 8.42x | 17.3x | 278x | -29.5x | -28.2x | 3.64x |
| PBR | 1.76x | 1.61x | 1.46x | 1.54x | 1.75x | 1.17x |
| PEG | - | -0.3x | -2.9x | 0x | -7.71x | -0x |
| Capitalization / Revenue | 44.3x | 61.1x | 36.6x | 22x | 19.5x | 20.5x |
| EV / Revenue | 48.2x | 62.1x | 38.1x | 23.5x | 22.3x | 23.1x |
| EV / EBITDA | -82x | -141x | 92.5x | 152x | 94.1x | -175x |
| EV / EBIT | -73.3x | -122x | 103x | 418x | 154x | -97.1x |
| EV / FCF | 6,826x | -5.65x | 4.54x | -13.9x | 547x | 132x |
| FCF Yield | 0.01% | -17.7% | 22% | -7.22% | 0.18% | 0.76% |
| Dividend per Share 2 | 0.9789 | 1.751 | 0.8179 | 1.36 | 0.6799 | 1.664 |
| Rate of return | 2.16% | 4.02% | 2.1% | 3.39% | 1.71% | 4.2% |
| EPS 2 | 5.383 | 2.519 | 0.1402 | -1.36 | -1.41 | 10.9 |
| Distribution rate | 18.2% | 69.5% | 583% | -100% | -48.2% | 15.3% |
| Net sales 1 | 717 | 500.1 | 767.7 | 1,394 | 1,618 | 1,516 |
| EBITDA 1 | -421.5 | -220.8 | 316.1 | 216 | 383.2 | -200.9 |
| EBIT 1 | -471.8 | -254.2 | 284.1 | 78.56 | 234.1 | -361.6 |
| Net income 1 | 3,786 | 1,816 | 102.2 | -995.4 | -1,104 | 9,323 |
| Net Debt 1 | 2,841 | 512.5 | 1,120 | 2,197 | 4,480 | 4,041 |
| Reference price 2 | 45.35 | 43.54 | 39.01 | 40.16 | 39.75 | 39.62 |
| Nbr of stocks (in thousands) | 699,786 | 701,772 | 721,156 | 762,726 | 794,720 | 783,789 |
| Announcement Date | 3/31/21 | 3/30/22 | 3/28/23 | 3/19/24 | 3/14/25 | 3/9/26 |
1TWD in Million2TWD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 754M | |
| 32.72x | 11.9x | 24.26x | 0.6% | 1,024B | |
| 30.62x | - | - | 1.95% | 663B | |
| 32.73x | 7.6x | 15.8x | 2.67% | 453B | |
| 19.89x | 4.73x | 11.71x | 2.8% | 352B | |
| 22.72x | 5.84x | 14.51x | 2.7% | 304B | |
| 20.87x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.66x | 7.14x | 13.15x | 2.31% | 236B | |
| 13.33x | 4.82x | 10.06x | 3.78% | 206B | |
| -46.14x | 6.65x | 25.95x | 2.18% | 187B | |
| Average | 17.16x | 6.62x | 15.96x | 2.34% | 367.91B | |
| Weighted average by Cap. | 24.05x | 7.99x | 17.80x | 1.95% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4123 Stock
- Valuation Center Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
